When Psoriasis Pretends to Be Eczema (And Other Problems)

Dermatology research and clinical management strategies center on evidence-based approaches for complex skin conditions. High-dose ivermectin provides no clinical superiority over standard dosing for treating crusted scabies, while ultrasound and CT imaging offer comparable efficacy in detecting nodal metastases for advanced cutaneous squamous cell carcinoma, despite reduced sensitivity in immunosuppressed patients. JAK inhibitors emerge as a preferred therapeutic strategy for patients exhibiting overlapping psoriasis and atopic dermatitis phenotypes, where traditional biologics often prove inadequate. Furthermore, ruxolitinib cream demonstrates significant improvement in the clinical signs of lichen sclerosis, such as architectural changes and fissures, even though it fails to achieve primary endpoints regarding patient-reported itch. These findings underscore the necessity of nuanced diagnostic and treatment protocols, particularly when managing recalcitrant conditions or patients with compromised immune systems.